Table 2 Baseline patient, angiographic and procedural characteristics according to diabetes status and revascularization assignment
Variable | No diabetes (n = 834) | Diabetes (n = 371) | ||||
|---|---|---|---|---|---|---|
Culprit-only PCI (n = 422) | Staged PCI (n = 412) | P value | Culprit-only PCI (n = 207) | Staged PCI (n = 164) | P value | |
Age (years) | 61 (52–70) | 58 (50–66) | 0.001 | 61 (53–69) | 59 (51–66) | 0.055 |
Male | 334 (79.1) | 341 (82.8) | 0.183 | 145 (70.0) | 135 (82.3) | 0.006 |
Current smoker | 225 (53.3) | 242 (58.7) | 0.115 | 98 (47.3) | 85 (51.8) | 0.391 |
Hypertension | 262 (62.1) | 233 (56.6) | 0.104 | 140 (67.6) | 102 (62.2) | 0.275 |
Dyslipidemia | 241 (57.1) | 239 (58.0) | 0.792 | 123 (59.4) | 107 (65.2) | 0.251 |
Previous myocardial infarction | 23 (5.5) | 16 (3.9) | 0.284 | 16 (7.7) | 10 (6.1) | 0.541 |
Previous PCI | 22 (5.2) | 20 (4.9) | 0.813 | 16 (7.7) | 12 (7.3) | 0.881 |
Previous stroke | 43 (10.2) | 31 (7.5) | 0.176 | 28 (13.5) | 16 (9.8) | 0.265 |
Peripheral vascular disease | 8 (1.9) | 12 (2.9) | 0.337 | 9 (4.3) | 7 (4.3) | 0.970 |
CKD in treatment | 13 (3.1) | 3 (0.7) | 0.013 | 6 (2.9) | 4 (2.4) | 1.000 |
OSAHS | 9 (2.1) | 5 (1.2) | 0.302 | 2 (1.0) | 0 (0) | 0.505 |
Heart rate (beats/min) | 76 (69–86) | 75 (67–84) | 0.010 | 78 (70–86) | 78 (70–85) | 0.884 |
Systolic blood pressure (mmHg) | 120 (107–130) | 120 (109–130) | 0.151 | 120 (108–130) | 120 (110–132) | 0.619 |
Laboratory data | ||||||
 Peak troponin (μg/L) | 68 (25–101) | 68 (30–114) | 0.076 | 76 (27–102) | 69 (28–108) | 0.735 |
 Peak CK (U/L) | 2110 (1088–3391) | 2076 (1156–3474) | 0.611 | 1974 (982–3360) | 1986 (1012–3311) | 0.918 |
 Peck CK-MB (U/L) | 239 (111–304) | 217 (128–307) | 0.865 | 180 (89–293) | 168 (68–300) | 0.963 |
Time from symptom onset to PCI (h) | 5.0 (3.0–8.0) | 4.0 (3.0–7.0) | 0.004 | 5.0 (3.0–8.0) | 5.0 (3.5–8.0) | 0.701 |
Killip class III/IV | 48 (11.4) | 26 (6.3) | 0.010 | 31 (15.0) | 15 (9.1) | 0.091 |
Radial artery access | 192 (45.5) | 103 (25.0) | < 0.001 | 101 (48.8) | 50 (30.5) | < 0.001 |
No. narrowed coronary arteries |  |  | < 0.001 |  |  | 0.082 |
 Two | 317 (75.1) | 263 (63.8) |  | 150 (72.5) | 105 (64.0) |  |
 Three | 105 (24.9) | 149 (36.2) |  | 57 (27.5) | 59 (36.0) |  |
Culprit vessel | Â | Â | 0.094 | Â | Â | 0.003 |
 Left anterior descending | 168 (39.8) | 157 (38.1) |  | 88 (42.5) | 50 (30.5) |  |
 Left circumflex | 46 (10.9) | 66 (16.0) |  | 18 (8.7) | 32 (19.5) |  |
 Right | 208 (49.3) | 189 (45.9) |  | 101 (48.8) | 82 (50.0) |  |
Non-culprit artery | ||||||
 Left anterior descending | 166 (39.3) | 204 (49.5) | 0.003 | 90 (43.5) | 88 (53.7) | 0.051 |
 Left circumflex | 246 (58.3) | 207 (50.2) | 0.020 | 115 (55.6) | 82 (50.0) | 0.287 |
 Right | 115 (27.3) | 151 (36.7) | 0.004 | 58 (28.0) | 53 (32.3) | 0.369 |
Thrombus aspiration | 284 (67.3) | 298 (72.3) | 0.114 | 133 (64.3) | 101 (61.6) | 0.597 |
No-reflow phenomenon | 46 (10.9) | 34 (8.3) | 0.194 | 23 (11.1) | 14 (8.5) | 0.411 |
Intra-aortic balloon pump use | 30 (7.1) | 53 (12.9) | 0.006 | 21 (10.1) | 15 (9.1) | 0.747 |
Glycoprotein IIb/IIIa inhibitor use | 103 (24.4) | 121 (29.4) | 0.106 | 55 (26.6) | 36 (22.0) | 0.304 |
Temporary pacemaker | 15 (3.6) | 5 (1.2) | 0.027 | 12 (5.8) | 3 (1.8) | 0.054 |
Defibrillator | 24 (5.7) | 19 (4.6) | 0.483 | 15 (7.2) | 3 (1.8) | 0.016 |
Drug-eluting stent use | 405 (96.0) | 404 (98.1) | 0.077 | 199 (96.1) | 161 (98.2) | 0.359 |
Type of stent | Â | Â | 0.280 | Â | Â | 0.153 |
 1st drug-eluting stent | 314 (74.4) | 320 (77.7) |  | 140 (67.6) | 125 (76.2) |  |
 2nd drug-eluting stent | 91 (21.6) | 84 (20.4) |  | 59 (28.5) | 36 (22.0) |  |
 Bare-mental stent | 1 (0.2) | 1 (0.2) |  | 2 (1.0) | 0 (0) |  |
 PTCA | 16 (3.8) | 7 (1.7) |  | 6 (2.9) | 3 (1.8) |  |
Stent number | 1 (1–2) | 1 (1–2) | 0.213 | 1 (1–2) | 1 (1–2) | 0.269 |
Total stent length (mm) | 33 (24–51) | 31 (24–46) | 0.010 | 33 (24–44) | 29 (23–41) | 0.141 |
Minimum stent diameter (mm) | 3.0 (2.5–3.5) | 3.0 (2.5–3.5) | 0.672 | 3.0 (2.5–3.5) | 3.0 (2.5–3.5) | 0.561 |
Medications at discharge | ||||||
 Aspirin | 421 (99.8) | 412 (100) | 1.000 | 207 (100) | 164 (100) | 1.000 |
 P2Y12 receptor inhibitor | 422 (100) | 412 (100) | 1.000 | 207 (100) | 164 (100) | 1.000 |
 ACEI/ARB | 290 (68.7) | 327 (79.4) | < 0.001 | 143 (69.1) | 126 (76.8) | 0.097 |
 β-blockers | 359 (85.1) | 334 (81.1) | 0.123 | 185 (89.4) | 146 (89.0) | 0.915 |
 Statins | 418 (99.1) | 408 (99.0) | 1.000 | 207 (100) | 163 (99.4) | 0.442 |
Acute kidney injurya | 80 (19.1) | 97 (23.6) | 0.113 | 37 (18.0) | 37 (22.6) | 0.272 |